Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Select Medical operates 104 critical illness recovery hospitals, 1,800+ outpatient rehabilitation clinics, and occupational health centers across 47 states, serving post-acute care patients transitioning from acute hospitals. The company also holds a 50.1% stake in Concentra, a leading occupational health provider with 540+ centers serving workers' compensation and employer health services. Revenue is driven by Medicare/Medicaid reimbursement rates, patient volumes, and labor cost management in a fragmented post-acute care market.
Select Medical generates revenue primarily through government reimbursement (Medicare/Medicaid ~60-65% of total) and commercial insurance for specialized post-acute care services. Critical illness hospitals earn higher per-patient reimbursement ($30,000-$50,000 per stay) but face strict Medicare admission criteria limiting volumes. Outpatient clinics operate on lower margins but benefit from recurring visit-based revenue and lower regulatory burden. Concentra provides stable cash flow through employer contracts and workers' comp referrals. Pricing power is limited by government rate-setting, making operational efficiency (labor productivity, length-of-stay management, utilization rates) the primary margin driver. Scale advantages exist in payor negotiations and overhead absorption across 2,400+ locations.
Medicare reimbursement rate changes and regulatory updates to LTACH admission criteria (Medicare Payment Advisory Commission recommendations)
Same-store patient volume growth in critical illness hospitals (average daily census) and outpatient clinic visit volumes
Labor cost inflation and nursing wage pressures relative to reimbursement rate increases
Concentra segment performance including workers' compensation claim volumes and employer health service contract wins
Acquisition activity and new clinic openings (historically 50-100 new outpatient locations annually)
Medicare reimbursement pressure and potential LTACH payment reforms as CMS seeks to reduce post-acute spending growth, with historical rate increases lagging medical cost inflation
Shift toward value-based care and bundled payments reducing fee-for-service volumes, particularly impacting standalone rehabilitation and LTACH utilization
Chronic healthcare labor shortages driving wage inflation (nursing, therapists) faster than reimbursement rate increases, compressing margins structurally
Competition from larger integrated health systems developing in-house post-acute capabilities and steering patients to owned facilities rather than independent providers like Select Medical
Private equity consolidation in outpatient rehabilitation creating larger regional competitors with enhanced payor negotiating leverage
Telehealth and home-based care models disrupting traditional clinic-based rehabilitation services, particularly for lower-acuity patients
Debt refinancing risk with $1.2B in borrowings requiring management attention as maturities approach, though current 0.61x D/E ratio is manageable
Capital intensity of maintaining and upgrading 2,400+ facilities creates ongoing capex requirements limiting cash available for debt reduction or shareholder returns
Accounts receivable concentration risk with government payors and potential for reimbursement delays or disputes impacting working capital
moderate - Post-acute care demand is relatively recession-resistant as critical illness volumes are non-discretionary, but outpatient rehabilitation and Concentra's occupational health services show cyclical sensitivity. During economic downturns, elective procedures decline reducing LTACH referrals, while workers' compensation volumes correlate with employment levels and workplace activity. Consumer spending impacts patient ability to meet co-pays and deductibles for outpatient services. However, aging demographics (65+ population growth) provide structural tailwind offsetting cyclical pressures.
Rising interest rates increase borrowing costs on Select Medical's $1.2B debt (mix of term loans and revolving credit), directly impacting interest expense and free cash flow available for growth investments. Higher rates also compress valuation multiples for healthcare services stocks as investors rotate to fixed income. However, the company's moderate leverage (0.61x D/E) and positive free cash flow generation ($500M TTM) limit refinancing risk. Rate increases have minimal direct impact on operating performance as reimbursement rates are government-determined rather than market-driven.
Moderate exposure - Select Medical's revenue depends on commercial insurance payor mix (~35-40% of revenue) where tighter credit conditions can increase bad debt expense as patients struggle with higher deductibles and co-pays. However, Medicare/Medicaid dominance (60-65% of revenue) provides stability. The company's own credit profile affects borrowing capacity for acquisitions and clinic expansion, with investment-grade aspirations requiring sustained deleveraging. Concentra's employer contracts provide more predictable cash flows less sensitive to consumer credit conditions.
value - The stock trades at 0.5x P/S and 1.2x P/B with 26.7% FCF yield, attracting deep value investors focused on cash generation and potential multiple re-rating. Recent 27% three-month rally suggests momentum investors entering after operational stabilization. The combination of government reimbursement exposure, labor cost pressures, and modest growth profile limits appeal to growth investors. Lack of dividend (implied by focus on debt paydown) reduces income investor interest. Hedge funds and distressed-oriented investors monitor given healthcare services sector volatility.
moderate-to-high - Healthcare services stocks exhibit elevated volatility driven by quarterly earnings surprises (census fluctuations, labor cost variability), regulatory announcement risk (CMS rule changes), and sector rotation dynamics. The -15.2% one-year return followed by recent 27% three-month surge demonstrates significant price swings. Post-acute care exposure creates event risk around Medicare policy changes. Moderate institutional ownership and $2B market cap contribute to liquidity-driven volatility during broader market stress.
